Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation

Nanotoxicology

Volumn 5, Issue 4, 2011, Pages 531-545

  Wingard, Christopher J ^a   Walters, Dianne M ^a   Cathey, Brook L ^a   Hilderbrand, Susana C ^a   Katwa, Pranita ^a   Lin, Sijie ^b   Ke, Pu Chun ^c   Podila, Ramakrishna ^c   Rao, Apparao ^c   Lust, Robert M ^a   Brown, Jared M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CLEMSON UNIVERSITY   (United States)

Author keywords

Ischemia reperfusion injury; Mast cell; Mast cell deficient mice; Osteopontin; Sash mice

Indexed keywords

ADENOSINE; CERIUM OXIDE; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NANOPARTICLE; OSTEOPONTIN; PROSTAGLANDIN D2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSAFETY; BLOOD VESSEL REACTIVITY; C57BL 6 MOUSE; CELL CULTURE; CHEMICAL REACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART MUSCLE ISCHEMIA; IMMUNE RESPONSE; MALE; MAST CELL; NONHUMAN; PARTICLE SIZE; PNEUMONIA; PRIORITY JOURNAL; REPERFUSION INJURY;

ADENOSINE; ANALYSIS OF VARIANCE; ANIMALS; AORTA, THORACIC; BRONCHOALVEOLAR LAVAGE FLUID; CERIUM; CHEMOKINE CCL3; GENE EXPRESSION REGULATION; HISTOCYTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-6; LUNG; MALE; MAST CELLS; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; OSTEOPONTIN; PARTICLE SIZE; PNEUMONIA; PROSTAGLANDIN D2; REPERFUSION INJURY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 80655125258     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2010.530004     Document Type: Article

References (44)

1. Bhattacharya K, Farwell K, Huang M, Kempuraj D, Donelan J, Papaliodis D, Vasiadi M, Theoharides TC. 2007. Mast cell deficient W/Wv mice have lower serum IL-6 and less cardiac tissue necrosis than their normal littermates following myocar-dial ischemia-reperfusion. Int J Immunopathol Pharmacol 20:69-74. (Pubitemid 46506877)
2. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I. 2004. Air pollution and cardiovascular disease: A statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109:2655-2671. (Pubitemid 38720571)
3. Brown JM, Swindle EJ, Kushnir-Sukhov NM, Holian A, Metcalfe DD. 2007. Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol 36:43-52. (Pubitemid 46067706)
4. Brown JM, Wilson TM, Metcalfe DD. 2008. The mast cell and allergic diseases: Role in pathogenesis and implications for therapy. Clin Exp Allergy 38:4-18. (Pubitemid 350233400)
5. Bulfone-Paus S, Paus R. 2008. Osteopontin as a new player in mast cell biology. Eur J Immunol 38:338-341.
6. Chen H, Li D, Saldeen T, Mehta JL. 2003. TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregu-lation of MMP-1. Am J Physiol Heart Circ Physiol 284: H1612-1617. (Pubitemid 36460773)
7. Colon J, Herrera L, Smith J, Patil S, Komanski C, Kupelian P, Seal S, Jenkins DW, Baker CH. 2009. Protection from radiation-induced pneumonitis using cerium oxide nanoparti-cles. Nanomedicine 5:225-231.
8. Cozzi E, Hazarika S, Stallings HW 3rd, Cascio WE, Devlin RB, Lust RM, Wingard CJ, Van Scott MR. 2006. Ultrafine partic-ulate matter exposure augments ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 291: H894-903. (Pubitemid 44175099)
9. Dileepan KN, Stechschulte DJ. 2006. Endothelial cell activation by mast cell mediators. Methods Mol Biol 315: 275-294.
10. Donaldson K, Mills N, MacNee W, Robinson S, Newby D. 2005. Role of inflammation in cardiopulmonary health effects of PM. Toxicol Appl Pharmacol 207:483-488.
11. Doyle MP, Linden J, Duling BR. 1994. Nucleoside-induced arte-riolar constriction: A mast cell-dependent response. Am J Physiol 266:H2042-2050.
12. Duffin R, Mills NL, Donaldson K. 2007. Nanoparticles-a thoracic toxicology perspective. Yonsei Med J 48:561-572.
13. Gojova A, Lee JT, Jung HS, Guo B, Barakat AI, Kennedy IM. 2009. Effect of cerium oxide nanoparticles on inflammation in vascular endothelial cells. Inhal Toxicol 21 (Suppl. 1):123-130.
14. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. 2005. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167:835-848. (Pubitemid 41216366)
15. Health Effects Institute 2001. Communication 9. Evaluation of Human Health Risk from Cerium Added to Diesel Fuel.
16. Kennedy IM, Wilson D, Barakat AI. 2009. Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line. Res Rep Health Eff Inst:3-32.
17. Kohan M, Breuer R, Berkman N. 2009. Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol 41:290-296.
18. Kossmehl P, Schonberger J, Shakibaei M, Faramarzi S, Kurth E, Habighorst B, von Bauer R, Wehland M, Kreutz R, Infanger M, Schulze-Tanzil G, Paul M, Grimm D. 2005. Increase of fibro-nectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med 41(3):290-296.
19. Lin S, Reppert J, Hu Q, Hudson JS, Reid ML, Ratnikova TA, Rao AM, Luo H, Ke PC. 2009. Uptake, translocation, and transmission of carbon nanomaterials in rice plants. Small 5:1128-1132.
20. Lin W, Huang YW, Zhou XD, Ma Y. 2006. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 25:451-457. (Pubitemid 44885100)
21. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R. 2006. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116: 1063-1070.
22. Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S. 2008. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 38:489-499.
23. Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE. 2007. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 73:549-559. (Pubitemid 46073957)
24. Okamoto H. 2007. Osteopontin and cardiovascular system. Mol Cell Biochem 300:1-7. (Pubitemid 46881810)
25. Park B, Donaldson K, Duffin R, Tran L, Kelly F, Mudway I, Morin JP, Guest R, Jenkinson P, Samaras Z, Giannouli M, Kouridis H, Martin P. 2008a. Hazard and risk assessment of a nanoparticulate cerium oxide-based diesel fuel additive-a case study. Inhal Toxicol 20:547-566. (Pubitemid 351601404)
26. Park B, Martin P, Harris C, Guest R, Whittingham A, Jenkinson P, Handley J. 2007. Initial in vitro screening approach to investigate the potential health and environmental hazards of Enviroxtrade mark-a nanoparticulate cerium oxide diesel fuel additive. Part Fibre Toxicol 4:12.
27. Park EJ, Choi J, Park YK, Park K. 2008b. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245:90-100.
28. Park EK, Thomas PS, Johnson AR, Yates DH. 2009. Osteopontin levels in an asbestos-exposed population. Clin Cancer Res 15:1362-1366.
29. Pedraza CE, Nikolcheva LG, Kaartinen MT, Barralet JE, McKee MD. 2008. Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications for bone wound healing. Bone 43:708-716.
30. Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML, Salmen R, Battelli LA, Willard PA, Hoover MD, Hubbs AF. 2003. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A 66:1441-1452. (Pubitemid 36976208)
31. Roberts AP, Mount AS, Seda B, Souther J, Qiao R, Lin S, Ke PC, Rao AM, Klaine SJ. 2007. In vivo biomodification of lipid-coated carbon nanotubes by Daphnia magna. Environ Sci Technol 41:3025-3029.
32. Rork TH, Wallace KL, Kennedy DP, Marshall MA, Lankford AR, Linden J. 2008. Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. Am J Physiol Heart Circ Physiol 295:H1825-1833.
33. Schack L, Stapulionis R, Christensen B, Kofod-Olsen E, Skov Sorensen UB, Vorup-Jensen T, Sorensen ES, Hollsberg P. 2009. Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J Immunol 182:6943-6950.
34. Shepherd RK, Duling BR. 1996. Inosine-induced vasoconstriction is mediated by histamine and thromboxane derived from mast cells. Am J Physiol 270:H560-566.
35. Shepherd RK, Linden J, Duling BR. 1996. Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor. Circ Res 78:627-634. (Pubitemid 26111055)
36. Spanier JE, Robinson RD, Zhang F, Chan S, Herman IP. 2001. Size-dependent properties of CeO2-y nanoparticles as studies by Raman scattering. Physical Rev B 64.
37. Takahashi A, Kurokawa M, Konno S, Ito K, Kon S, Ashino S, Nishimura T, Uede T, Hizawa N, Huang SK, Nishimura M. 2009. Osteopontin is involved in migration of eosinophils in asthma. Clin Exp Allergy 39:3323-3330.
38. Thill A, Zeyons O, Spalla O, Chauvat F, Rose J, Auffan M, Flank AM. 2006. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ Sci Technol 40: 6151-6156. (Pubitemid 44507274)
39. Walczak-Drzewiecka A, Wyczolkowska J, Dastych J. 2003. Environmentally relevant metal and transition metal ions enhance Fc epsilon RI-mediated mast cell activation. Environ Health Perspect 111:708-713. (Pubitemid 36621600)
40. Wang KX, Denhardt DT. 2008. Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev 19:333-345.
41. Wolters PJ, Mallen-St Clair J, Lewis CC, Villalta SA, Baluk P, Erle DJ, Caughey GH. 2005. Tissue-selective mast cell reconsti-tution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy 35:82-88. (Pubitemid 40188275)
42. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2: 2121-2134.
43. Yin BL, Hao H, Wang YY, Jiang YJ, Xue S. 2009. Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells. Inflamm Res 58: 67-73.
44. Zhao J, Xie Y, Qian X, Jiang R, Song W. 2010. Acute effects of fine particles on cardiovascular system: Differences between the spontaneously hypertensive rats and wistar kyoto rats. Toxicol Lett 193:50-60.